Vogliviga GM1/0.3 Tablet in PCD pharma franchise in Hyderabad

Vogliviga GM1/0.3 Tablet in pharmaceutical manufacturing company in Mumbai

Vogliviga GM1/0.3 Tablet in diabetic pharma franchise in Pune

Vogliviga GM1/0.3 Tablet in pharma suppliers in Delhi

Vogliviga GM1/0.3 Tablet in pharma export companies in Kolkata
Vogliviga GM1/0.3 Tablet in pharma franchise opportunities in Bengaluru

Vogliviga GM1-0.3 Tablet

Composition : Glimepiride I.P. 1mg + Voglibose I.P. 0.3mg + Metformin HCL I.P. 500mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹189/-

Please Contact For Best Price

Vogliviga GM1/0.3 Tablet contains Glimepiride 1mg, Voglibose 0.3mg, and Metformin 500mg in a bi-layered formulation to effectively manage type 2 diabetes mellitus. Glimepiride promotes insulin secretion, Voglibose helps reduce post-meal blood sugar spikes by slowing carbohydrate absorption, and Metformin improves insulin sensitivity while decreasing hepatic glucose production. This combination ensures comprehensive blood sugar control throughout the day.

Read More

About the Product

Vogliviga GM1/0.3 Tablet contains Glimepiride 1mg, Voglibose 0.3mg, and Metformin 500mg in a bi-layered formulation to effectively manage type 2 diabetes mellitus. Glimepiride promotes insulin secretion, Voglibose helps reduce post-meal blood sugar spikes by slowing carbohydrate absorption, and Metformin improves insulin sensitivity while decreasing hepatic glucose production. This combination ensures comprehensive blood sugar control throughout the day.

Possible side effects include nausea, abdominal discomfort, bloating, diarrhea, and risk of hypoglycemia. Long-term use may lead to vitamin B12 deficiency. Patients should monitor blood glucose regularly.

It is prescribed for the treatment of type 2 diabetes, particularly for patients needing control of both fasting and postprandial glucose levels.

Not recommended for patients with type 1 diabetes, severe kidney or liver impairment, or diabetic ketoacidosis. Alcohol should be avoided during treatment. Follow medical advice strictly and report any unusual symptoms.

Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch